1-10 of 10
Authors: Rona Smith
Save search
Sort by
Journal Article

Predictors of hypogammaglobulinemia in ANCA-associated vasculitis after a rituximab-based induction: a multicentre study

PDF
Manuel Alfredo Podestà and others
Rheumatology, Volume 62, Issue 8, August 2023, Pages 2850–2854, https://doi.org/10.1093/rheumatology/keac716
Published: 23 December 2022
Journal Article
EDITOR'S CHOICE

High risk of stroke in ANCA-associated vasculitis—a population-based study

PDF
Dennis Tabakovic and others
Rheumatology, Volume 62, Issue 8, August 2023, Pages 2806–2812, https://doi.org/10.1093/rheumatology/keac669
Published: 28 November 2022
Journal Article

Complications of therapy for ANCA-associated vasculitis Get access

PDF
Rona Smith
Rheumatology, Volume 59, Issue Supplement_3, May 2020, Pages iii74–iii78, https://doi.org/10.1093/rheumatology/kez618
Published: 29 April 2020
Journal Article

Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines

PDF
Joanna Tieu and others
Rheumatology, Volume 59, Issue 4, April 2020, Pages e24–e32, https://doi.org/10.1093/rheumatology/kez640
Published: 26 March 2020
Journal Article
EDITOR'S CHOICE

Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines—Executive summary

PDF
Joanna Tieu and others
Rheumatology, Volume 59, Issue 4, April 2020, Pages 727–731, https://doi.org/10.1093/rheumatology/kez632
Published: 24 February 2020
Journal Article

302. ALEMTUZUMAB FOR RELAPSING AND REFRACTORY PRIMARY SYSTEMIC VASCULITIS – A TRIAL OF EFFICACY AND SAFETY (ALEVIATE): A RANDOMISED OPEN-LABEL PHASE II CLINICAL TRIAL

PDF
Seerapani Gopaluni and others
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez063.026, https://doi.org/10.1093/rheumatology/kez063.026
Published: 29 March 2019
Journal Article

335. ALEMTUZUMAB FOR THE TREATMENT OF REFRACTORY BEHÇET’S DISEASE: A SUBGROUP ANALYSIS FROM A RANDOMIZED, PROSPECTIVE, OPEN LABEL, DOSE RANGING CLINICAL TRIAL (NCT01405807). A TRIAL OF EFFICACY AND SAFETY (ALEVIATE)

PDF
Maria Prasinou and others
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez063.059, https://doi.org/10.1093/rheumatology/kez063.059
Published: 29 March 2019
Journal Article

029. PR3-ANCA STATUS FOLLOWING RITUXIMAB: A USEFUL BIOMARKER FOR RELAPSE PREDICTION IN ANCA-ASSOCIATED VASCULITIS

PDF
Mark McClure and others
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.028, https://doi.org/10.1093/rheumatology/kez057.028
Published: 29 March 2019
Journal Article

356. RITUXIMAB ASSOCIATED HYPOGAMMAGLOBULINAEMIA IN AUTOIMMUNE DISEASE: LONG TERM OUTCOMES

PDF
Joanna Tieu and others
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez063.080, https://doi.org/10.1093/rheumatology/kez063.080
Published: 29 March 2019
Journal Article

Progressive multifocal leucoencephalopathy with Behçet’s disease: an insight into pathophysiology Get access

PDF
Smriti Agarwal and others
Rheumatology, Volume 56, Issue 4, April 2017, Pages 668–670, https://doi.org/10.1093/rheumatology/kew404
Published: 26 December 2016